| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2016 | 151P: Outcomes of research biopsies in clinical trials of EGFR mutation-positive NSCLC patients pretreated with EGFR-TKIs | Liao B.-C.; Bai Y.-Y.; Lin C.-C.; Lin S.-Y.; Lee Y.-F.; CHAO-CHI HO ; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Yang J. | Journal of Thoracic Oncology | 1 | 1 | |
| 2016 | 205P: Visualizing ZO-1-mediated coupled migration between cancer and stromal cells in lung cancer metastasis via a 5-dimensional cell imaging system | Lu H.-H.; Chen B.-C.; Chen H.-W.; CHAO-CHI HO ; Yu C.-J. | Journal of Thoracic Oncology | 0 | 0 | |
| 2002 | 8 Role of immunohistochemical expression of caveolin-1 in lung carcinoma | CHAO-CHI HO ; Huang P.-H.; Yang P.-C.; Hsu S.-M. | Handbook of Immunohistochemistry and in Situ Hybridization of Human Carcinomas | 0 | 0 | |
| 2017 | Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib | CHAO-CHI HO ; Liao W.-Y.; Lin C.-A.; Shih J.-Y.; Yu C.-J.; Chih-Hsin Yang J. | Journal of Thoracic Oncology | 88 | 128 | |
| 2011 | Admissions to intensive care unit of HIV-infected patients in the era of highly active antiretroviral therapy: Etiology and prognostic factors | Chiang H.-H.; Hung C.-C.; Lee C.-M.; Chen H.-Y.; Chen M.-Y.; Sheng W.-H.; Hsieh S.-M.; Sun H.-Y.; CHAO-CHI HO ; Yu C.-J. | Critical Care | 47 | 48 | |
| 2008 | Adrenal insufficiency in prolonged critical illness | Wu J.-Y.; Hsu S.-C.; Ku S.-C.; CHAO-CHI HO ; Yu C.-J.; Yang P.-C. | Critical Care | 15 | 14 | |
| 2012 | Advanced non-small cell lung cancer in patients aged 45 years or younger: Outcomes and prognostic factors | Hsu C.-L.; Chen K.-Y.; Shih J.-Y.; CHAO-CHI HO ; Yang C.-H.; Yu C.-J.; Yang P.-C. | BMC Cancer | 62 | 57 | |
| 2014 | Afatinib combined with cetuximab for lung adenocarcinoma with leptomeningeal carcinomatosis | Lin C.-H.; Lin M.-T.; Kuo Y.-W.; CHAO-CHI HO | Lung Cancer | 20 | 20 | |
| 2021 | Afatinib Exerts Immunomodulatory Effects by Targeting the Pyrimidine Biosynthesis Enzyme CAD | Tu, Hsin-Fang; Ko, Chun-Jung; Lee, Ching-Tai; Lee, Cheng-Fan; Lan, Shao-Wei; Lin, Hsin-Hsien; Lin, Hsin-Ying; CHIA-CHI KU; Lee, Der-Yen; Chen, I-Chun; Chuang, Ya-Hui; Del Caño-Ochoa, Francisco; Ramón-Maiques, Santiago; CHAO-CHI HO ; Lee, Ming-Shyue; Chang, Geen-Dong | Cancer research | | 4 | |
| 2020 | Antimetabolite pemetrexed primes a favorable tumor microenvironment for immune checkpoint blockade therapy | Lu C.-S.; Lin C.-W.; Chang Y.-H.; Chen H.-Y.; Chung W.-C.; Lai W.-Y.; CHAO-CHI HO ; Wang T.-H.; Chen C.-Y.; Yeh C.-L.; Wu S.; Wang S.-P.; Yang P.-C. | Journal for ImmunoTherapy of Cancer | | 7 | |
| 2020 | Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors | Yang C.-Y.; Liao W.-Y.; CHAO-CHI HO ; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. | European Journal of Cancer | 3 | 24 | |
| 2020 | Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib | Yang C.-Y.; Liao W.-Y.; CHAO-CHI HO ; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. | Oncologist | 0 | 8 | |
| 2017 | Astrocyte-elevated gene-1 confers resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase expression | Chen C.-Y.; Chen Y.-Y.; Chen J.J.W.; Chen K.-Y.; CHAO-CHI HO ; Shih J.-Y.; Chang Y.-L.; Yu C.-J.; Yang P.-C. | Oncotarget | 4 | 7 | |
| 2019 | Atypical cells in pathology of endobronchial ultrasound-guided transbronchial biopsy of peripheral pulmonary lesions: incidence and clinical significance | Huang C.-T.; Tsai Y.-J.; CHAO-CHI HO ; Yu C.-J. | Surgical Endoscopy | 2 | 3 | |
| 2014 | Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer | Lee J.-H.; Lin Y.-L.; Hsu W.-H.; Chen H.-Y.; Chang Y.-C.; Yu C.-J.; Shih J.-Y.; Lin C.-C.; Chen K.-Y.; CHAO-CHI HO ; Laio W.-Y.; Yang P.-C.; Yang J.C.-H. | Journal of Thoracic Oncology | 38 | 34 | |
| 2018 | Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non–Small-cell Lung Cancer Patients | Wu T.-H.; Hsiue E.H.-C.; Lee J.-H.; Lin C.-C.; Liao W.-Y.; CHAO-CHI HO ; Shih J.-Y.; Yu C.-J.; Yang J.C.-H. | Clinical Lung Cancer | 7 | 12 | |
| 2006 | C2GnT-M is downregulated in colorectal cancer and its re-expression causes growth inhibition of colon cancer cells | Huang M.-C.; Chen H.-Y.; Huang H.-C.; Huang J.; Liang J.-T.; Shen T.-L.; Lin N.-Y.; CHAO-CHI HO ; Cho I.-M.; Hsu S.-M. | Oncogene | 61 | 61 | |
| 2014 | Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling | Chen W.-J.; CHAO-CHI HO ; Chang Y.-L.; Chen H.-Y.; Lin C.-A.; Ling T.-Y.; Yu S.-L.; Yuan S.-S.; Louisa Chen Y.-J.; Lin C.-Y.; Pan S.-H.; Elizabeth Chou H.-Y.; Chang G.-C.; Chu W.-C.; Lee Y.-M.; Lee J.-Y.; Lee P.-J.; Li K.-C.; Chen H.-W.; Yang P.-C. | Nature Communications | 165 | 236 | |
| 2008 | Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy | CHAO-CHI HO ; Kuo S.-H.; Huang P.-H.; Huang H.-Y.; Yang C.-H.; Yang P.-C. | Lung Cancer | 94 | 94 | |
| 2012 | Central venous oxygen saturation under non-protocolized resuscitation is not related to survival in severe sepsis or septic shock | Chung K.-P.; Chang H.-T.; Huang Y.-T.; Liao C.-H.; CHAO-CHI HO ; Jerng J.-S.; Yu C.-J. | Shock | 15 | 16 | |
